Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Leukemia Research|November 13, 2023
How low can you go?: Methodologic considerations in clonal hematopoiesis variant callingJ Scott Beeler, Kelly L BoltonBMC Public Health|March 10, 2009
Smoking, drinking and body weight after re-employment: does unemployment experience and compensation make a difference?Kelly L Bolton, Eunice RodriguezBlood|August 1, 2020
What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinicsDavid P Steensma, Kelly L BoltonBlood|July 6, 2026
Decentralized Clinical Trials in Hematology: the Promise and the PerilGiulia Petrone, Geoffrey L Uy, Kelly L BoltonAmerican Journal of Hematology|January 9, 2026
Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenias of Undetermined Significance: 2026 Update on Clinical Associations and Management RecommendationsAbhishek A Mangaonkar, Kelly L Bolton, Mrinal M PatnaikHaematologica|February 5, 2026
Clonal hematopoiesis and its progression to myeloid neoplasms: insights into risk, biology, and therapeutic strategiesScott J Beeler, Matthew J Walter, Kelly L BoltonAnnual Review of Genomics and Human Genetics|August 27, 2024
Clinical and Therapeutic Implications of Clonal HematopoiesisGiulia Petrone, Isik Turker, Pradeep Natarajan, et al.Frontiers in Oncology|February 25, 2022
What Clonal Hematopoiesis Can Teach Us About MDSIrenaeus C C Chan, Brian J Wiley, Kelly L BoltonNature Genetics|March 12, 2026
CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesisIrenaeus C C Chan, Pu Zhang, Xiangyu Pan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm RiskDuc Tran, J Scott Beeler, Jie Liu, et al.Pageof 8